Clinical Trial Update: INSTI's For The Management of HIV-associated TB [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating an integrase inhibitor (INSTI)–based regimen for HIV-associated tuberculosis has completed enrollment and posted results. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids
• Pulmonary Tuberculosis
• Tuberculosis

Drugs mentioned

• Integrase inhibitor (INSTI) class (integrase strand transfer inhibitor)

Snippet

Sponsor: Centre for the AIDS Programme of Research in South Africa | Conditions: HIV/AIDS, Tuberculosis, Pulmonary | Phase 2 | Status: COMPLETED | Results posted: 2025-08-15